MiR-195 inhibits myocardial fibrosis in hypertensive rats by regulating TGFβ1-Smad3 signaling pathway.

Xu Q, Lin XX, Liu P, Zhang W, Tang K, Zhai YS, Liu LJ, Mei WY

Open source

DOI
10.26355/eurrev_201909_19026
Published
2019 Sep
Container
European review for medical and pharmacological sciences
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.26355/eurrev_201909_19026,
  title = {MiR-195 inhibits myocardial fibrosis in hypertensive rats by regulating TGFβ1-Smad3 signaling pathway.},
  author = {Xu Q and Lin XX and Liu P and Zhang W and Tang K and Zhai YS and Liu LJ and Mei WY},
  year = {2019},
  journal = {European review for medical and pharmacological sciences},
  doi = {10.26355/eurrev_201909_19026},
  url = {https://doi.org/10.26355/eurrev_201909_19026}
}

RIS

TY  - JOUR
TI  - MiR-195 inhibits myocardial fibrosis in hypertensive rats by regulating TGFβ1-Smad3 signaling pathway.
AU  - Xu Q
AU  - Lin XX
AU  - Liu P
AU  - Zhang W
AU  - Tang K
AU  - Zhai YS
AU  - Liu LJ
AU  - Mei WY
PY  - 2019
JO  - European review for medical and pharmacological sciences
DO  - 10.26355/eurrev_201909_19026
UR  - https://doi.org/10.26355/eurrev_201909_19026
ER  - 

APA

Q, X., XX, L., P, L., W, Z., K, T., YS, Z., LJ, L., & WY, M. (2019). MiR-195 inhibits myocardial fibrosis in hypertensive rats by regulating TGFβ1-Smad3 signaling pathway.. European review for medical and pharmacological sciences. https://doi.org/10.26355/eurrev_201909_19026

Source records